4SC Reports Positive Data from Clinical Phase I trial with 4SC-205 in Cancer Patients

News   Mar 28, 2013

 
4SC Reports Positive Data from Clinical Phase I trial with 4SC-205 in Cancer Patients
 
 
 

RELATED ARTICLES

Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

BC Platforms Announces Collaborations in Multiple Sclerosis Research

News

Company's technology and research platforms used to better understand genetic basis of MS.

READ MORE

Pathway in Neurons may Contribute to Neurodegenerative Disease

News

Pathway has received attention as potential drug target.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE